Physician profile
Alexandra Boster
NPI 1366837098
$1,768.38
in general payments reported to CMS, 2019-2025
19 companies · $506 in 2025
The $506 reported for 2025 was more than what 81% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $53.77 · 2020: $46.04 · 2021: $89.60 · 2022: $190 · 2023: $660 · 2024: $222 · 2025: $506.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,290 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,289.82 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $401.49 | 2023 | Myfembree |
| Astellas Pharma US INC | $380.41 | 2023-2025 | Veozah |
| Abbvie INC. | $239.76 | 2019-2023 | Lo Loestrin Fe |
| Myovant Sciences INC. | $124.99 | 2022 | |
| Exeltis, USA INC. | $106.97 | 2019-2025 | Slynd |
| Mayne Pharma Commercial LLC | $94.41 | 2023-2025 | |
| Daiichi Sankyo INC. | $81.13 | 2021-2025 | Injectafer |
| Pfizer INC. | $47.64 | 2019-2021 | |
| Organon LLC | $43.63 | 2024-2025 | Nexplanon |
| Hologic Sales and Service, LLC | $42.24 | 2025 | Aptima, Thinprep 2000 Processor |
| Exact Sciences Corporation | $42.03 | 2025 | The Cologuard Plus Collection Kit |
| Shield Therapeutics INC | $35.20 | 2023-2024 | Accrufer |
| Millicent US INC | $23.20 | 2024 | Femring, Intrarosa |
| Sage Therapeutics, LLC | $21.18 | 2024 | |
| Evofem Biosciences, INC. | $20.00 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $16.70 | 2023 | |
| Ethicon US, LLC | $16.61 | 2020 | |
| Coopersurgical, INC. | $16.15 | 2023 | Endosee |
| Therapeuticsmd, INC. | $14.64 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexandra Boster listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.